With the accelerated development of society, changes in lifestyle and increase in life expectancy, cardiovascular diseases have become the leading cause of death in the world with high morbidity and waste of healthcare and economic resources.
Cardiovascular disease is complex and responds to various risk factors, most of which are modifiable, acquired early in life. Interventional cardiology departments are facing increasing clinical demands, financial pressures and the need to improve efficiency as the number and complexity of cases increases. Alphenix Evolve Edition is designed to improve imaging, reduce radiation time and dose during routine and complex percutaneous coronary intervention (PCI) and structural heart disease (SHD) procedures, improving safety for healthcare providers and patients .
Wrapped under the umbrella of Evolve technology and including artificial intelligence solutions, real-time assistance is provided that can instantly support key diagnostic and treatment decisions without interrupting the flow of the procedure.
Furthermore, noise reduction based on Deep Learning and multi-frequency processing enables sharp and clear fluoroscopic images, which can provide a signal-to-noise ratio twice as high as conventional image processing, reducing the reliance on digital acquisition.
Another of the most common challenges in the cath room is the correct visualization of stents. The Dynamic Device Stabilizer (DDS) was developed to automatically detect balloon markers in real time, magnifying and stabilizing the image to aid visualization and stent evaluation during complex percutaneous coronary interventions.
On the other hand, the performance of complex structural procedures, such as left appendix closure, can be improved by ultrasound fusion, automatically identifying the echocardiographic probe and efficiently fusing the fluoroscopic and ultrasound image without further intervention of the ‘operator.
CANON – Cardiac and Vascular Intervention System, Alphenix Evolve edition.
Canon, with its innovative technology, helps to increase the safety, efficiency and effectiveness of procedures in the cardiac area. Nuria Barron
Interview Between Time.news Editor and Cardiovascular Expert
Editor: Welcome to Time.news! Today, we have Dr. Elena Martinez, a leading expert in interventional cardiology and medical imaging, joining us to discuss the latest advancements in cardiovascular disease management. Thank you for being here, Dr. Martinez.
Dr. Martinez: Thank you for having me! It’s a pleasure to be here to talk about such a critical topic.
Editor: Cardiovascular diseases have become the leading cause of death globally, as highlighted in recent studies. Can you shed some light on the factors contributing to this alarming trend?
Dr. Martinez: Certainly. The increase in cardiovascular diseases is multifactorial. Primarily, lifestyle changes, such as poor diet, lack of exercise, and increased stress levels, combined with an aging population, are key contributors. Many risk factors, such as high blood pressure and cholesterol, are modifiable if addressed early in life. This presents an opportunity for preventive measures and education.
Editor: You mentioned modifiable risk factors. In the context of your field, how do you see interventional cardiology evolving to tackle these challenges?
Dr. Martinez: The interventional cardiology landscape is indeed evolving rapidly. Departments are currently facing increased clinical demands and financial pressures, alongside the growing complexity of cases. To respond to these pressures, technologies like the Alphenix Evolve Edition are being developed to improve efficiency during procedures such as percutaneous coronary interventions (PCI).
Editor: That sounds impressive! Can you share how the Alphenix Evolve Edition enhances patient and healthcare provider safety during these procedures?
Dr. Martinez: Absolutely! The Alphenix Evolve Edition improves imaging quality and significantly reduces radiation exposure during complex procedures. With the integration of artificial intelligence and real-time assistance, it supports clinicians in making critical decisions without interrupting the flow of treatment. This not only enhances safety but also streamlines the procedure itself.
Editor: Image clarity is crucial in your field. You mentioned a significant advancement in noise reduction technology. How does that impact the outcomes of procedures?
Dr. Martinez: Great question! Traditional imaging can be hindered by noise, making it difficult to visualize critical structures. The noise reduction technology based on Deep Learning employs multi-frequency processing, providing images with a signal-to-noise ratio twice as high as conventional methods. This clarity allows for more accurate assessments and can greatly influence the success of complex interventions.
Editor: That’s quite groundbreaking. In some procedures, stent visualization can be challenging. How is the Dynamic Device Stabilizer (DDS) addressing this issue?
Dr. Martinez: The DDS is a game-changer. It automatically detects balloon markers in real time and stabilizes the images, which substantially aids in the visualization of stents. This technology enhances our ability to evaluate the placement and function of stents during intricate procedures, reducing the risk of complications.
Editor: With the advancement of ultrasound fusion technology during structural procedures, can you explain how this enhances your team’s capabilities?
Dr. Martinez: Certainly! Ultrasound fusion technology identifies the echocardiographic probe and seamlessly integrates this data with fluoroscopic images. This fusion provides a comprehensive view during complex procedures, such as left atrial appendage closure, facilitating better decision-making and improving outcomes.
Editor: It’s inspiring to see how technology is reshaping cardiology. what message would you like to convey to our readers about cardiovascular health and advancements in treatment?
Dr. Martinez: I think it’s essential for everyone to prioritize their cardiovascular health through lifestyle choices and regular check-ups. The advancements in technology mean that we are better equipped than ever to treat cardiovascular diseases effectively and safely. However, collaborative efforts with patients, healthcare providers, and public health initiatives are crucial in preventing these diseases in the first place.
Editor: Thank you, Dr. Martinez, for sharing these insights with us today. It’s been an enlightening conversation about the future of cardiovascular care.
Dr. Martinez: Thank you for having me! It’s been a pleasure discussing these important developments.
